CART "Advances in Autism 2018" Symposium

Behavioral Treatment

Behavioral treatments: How has it changed and where are we going next?

Amanda Gulsrud, PhD

A randomized trial comparing intervention environment and peer composition

Michelle Dean, PhD

Evidence-based treatments to improve social outcomes in adults with ASD

Elizabeth Laugeson, PsyD

Genetics

Diagnostic genetic testing and its role in the clinical management of autism

Julian Martinez, MD, PhD

Advances in the genetics of autism: Implications for therapy

Daniel H. Geschwind, MD, PhD

Neuroimaging

Update on Brain Research in Autism

Susan Bookheimer, PhD

Neuroimaging Markers of Atypical Attentional Biases in Very Young Infants at High Risk for ASD

Mirella Dapretto, PhD

Psychopharmacology

Is there a pill for that?: What we know and don’t know about ASD Psychopharmacology

Benjamin Schneider, MD

The Cutting-Edge of ASD Treatment Research

James McCracken, MD

Biomarkers/Outcome Measures

Outcome Measures in Autism: Challenges and Considerations

Charlotte DiStefano, PhD

Biomarkers and clinical trials in autism…on the road to precision health

Shafali Spurling Jeste, MD

Ask the Expert

Ask the Expert Panel

Facilitator: Shafali Jeste, MD
Panelists: Susan Bookheimer, PhD, Mirella Dapretto, PhD, Michelle Dean, PhD, Daniel H. Geschwind, MD, PhD, Amanda Gulsrud, PhD, Elizabeth Laugeson, PsyD, James McCracken, MD, Julian Martinez, MD, PhD, Charlotte DiStefano, PhD